APC and neoplasm: A commonly employed colorectal cancer mice model exploits the deletion of tumor suppressor gene, Apc, providing a target for the development of murine tumor organoids via CRISPR-Cas9, useful for assessing the function of genes in the context of tumorigenesis [139].